Contribution: Industrial Research Assistance Program – Contributions to Firms
Granville Biomedical Inc.
$188,412.00
Research and Development of a Pharmacogenetic Buccal Swab for use in DNA Custom Medicine Genetic Testing
FY 2021-22 · 2021-07-26
Summary
Granville Biomedical has identified a Canadian market opportunity to develop and validate a novel buccal swab for oral cellular specimen collection which meets regulatory and customer needs.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Mount Pearl|Mount Pearl, Newfoundland and Labrador, Canada
Recipient Type
For-profit organization
Business Number
708322318
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-07-26 | 2021-22 | $118,500.00 |
| 2 | 2021-07-26 | 2021-22 | $163,412.00 |
| 3 | 2021-07-26 | 2021-22 | $188,412.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 16 days. The total amended value is 25,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 16 jours. La valeur totale des modifications est de 25 000 dollars.
Agreement End Date
2022-09-16
Agreement Number
976581
Agreement Start Date
2021-07-26
Agreement Title
Research and Development of a Pharmacogenetic Buccal Swab for use in DNA Custom Medicine Genetic Testing
Agreement Title (French)
Recherche et développement d'un écouvillon buccal pharmacogénétique destiné à être utilisé dans les tests génétiques de médecine personnalisée par l'ADN
Agreement Type
Contribution
Agreement Value
$188,412.00
Amendment Date
2022-07-20
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Granville Biomedical has identified a Canadian market opportunity to develop and validate a novel buccal swab for oral cellular specimen collection which meets regulatory and customer needs.
Description (French)
Granville Biomedical a repéré une possibilité sur le marché canadien pour mettre au point et valider un nouvel écouvillon buccal pour le prélèvement d'échantillons cellulaires oraux, qui répond aux besoins de la réglementation et des clients.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
St. John's South--Mount Pearl
Federal Riding (French)
St. John's-Sud--Mount Pearl
Federal Riding Number
10007
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
708322318
Recipient City
Mount Pearl|Mount Pearl
Recipient Country
CA
Recipient Legal Name
Granville Biomedical Inc.
Recipient Operating Name
Granville Biomedical
Recipient Postal Code
A1N 2Z5
Recipient Province or Territory
NL
Recipient Type
F
Reference Number
172-2021-2022-Q2-976581
